SUPPLEMENTARY TABLES
Table S1. PCR product specifications.
Table S2. Detailed material information.
Table S1. PCR product specifications.
Gene Assay ID or Sequence ID System specification
miR-126-3p ID 002228 TaqMan MicroRNA Assay, Applied Biosystems
miR-126-5p ID 000451 TaqMan MicroRNA Assay, Applied Biosystems
miR-628-5p ID 002433 TaqMan MicroRNA Assay, Applied Biosystems
miR-92a-3p ID 000431 TaqMan MicroRNA Assay, Applied Biosystems
U6 ID 001973 TaqMan MicroRNA Assay, Applied Biosystems
VCAM1 Hs1003372_m1 TaqMan Gene Expression Assay, Applied Biosystems
PIK3R2 Hs00178181_m1 TaqMan Gene Expression Assay, Applied Biosystems
SPRED1 Hs01084559_m1 TaqMan Gene Expression Assay, Applied Biosystems
DLK1 Hs00171584_m1 TaqMan Gene Expression Assay, Applied Biosystems
GAPDH Hs99999905_m1 TaqMan Gene Expression Assay, Applied Biosystems
Table S2. Detailed material information
Procedure Name of kit Company Country Catalog number
microRNA and 
RNA extraction
miRVANA miRNA 
isolation kit Ambion USA AM1560
microRNA cDNA 
synthesis
TaqMan MicroRNA 
Reverse Transcription Kit
Applied 
Biosystems USA 4366596
mRNA cDNA 
synthesis
High-Capacity cDNA 
Reverse Transcription Kit
Applied 
Biosystems USA 4368813
microRNA cDNA 
amplification
TaqMan Universal Master 
Mix II, no UNG
Applied 
Biosystems USA 4440047
mRNA cDNA 
amplification
TaqMan Universal PCR 
Master Mix, no 
AmpErase UNG
Applied 
Biosystems USA 4364341

HIGHLIGHTS
• Cardiac allograft vasculopathy coincides with lower miR-126a-3p levels in endomyocardial biopsies 
of heart transplant recipients.
• MiR-126 and its targets are influenced by the administration of immunosuppressive agents in human 
microvascular cardiac endothelial cells.
• The use of microRNA or other biomarkers can be of added value to detect cardiac allograft 
vasculopathy thereby avoiding invasive angiography.

